Implantable Provider Group (IPG) Company Profile

23:58 EST 9th December 2018 | BioPortfolio

News Articles [1018 Associated News Articles listed on BioPortfolio]

North America Implantable Cardiac Monitors Market Report 2018

The North America Implantable Cardiac Monitors Market is expected to witness market growth of 6.8% CAGR during the forecast period 2017-2023 The implantable cardiac monitor, Read more...

Clanwilliam Group acquires NHS tech provider Informatica Systems in global expansion

An NHS technology provider that helps GPs to predict when specific patients are at risk of developing chronic diseases, and that allows planners to track... The post Clanwilliam Group acquires NHS tec...

First implantable glucose monitor approved by FDA

The first continuous glucose monitoring system with a fully implantable sensor has been approved by the US Food and Drug Administration.

FDA OKs Personal Therapy App for Implantable Pain Pump

The myPTM app works with the company's implantable pain pump and allows patients to personalize their chronic pain medication within pre-set therapeutic limits. FDA Approvals

Medtronic's drug-delivery system for United's PAH drug wins FDA nod

The FDA has approved Medtronic's Implantable System for Remodulin, which includes the SynchroMed II implantable pump and an i -More- 

STAAR Surgical's implantable lens wins FDA nod

STAAR Surgical has obtained approval from the FDA for its Visian Toric Implantable Collamer Lens for treatment of myopia with -More- 

More Funds, New Tech Needed To Diagnose Lyme Disease, US Work Group Says

A US federal working group focusing on tick-borne diseases is recommending more funds from Congress for Lyme disease diagnostic test...   

Postmortem Cardiac Implantable Device Interrogation Useful

TUESDAY, Aug. 7, 2018 -- Postmortem cardiac implantable electronic device (CIED) interrogation can improve the accuracy of identification of the time and cause of death at forensic autopsy, according ...

Drugs and Medications [167 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Androgel [Abbott Products, Inc.]

These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%.AndroGel (testosterone gel) 1.62% for topic...

Ciprofloxacin [NorthStar Rx LLC]

Ciprofloxacin Tablets, USP

Lamotrigine [American Health Packaging]

LAMOTRIGINE TABLETS (Chewable, Dispersible)

PubMed Articles [2190 Associated PubMed Articles listed on BioPortfolio]

Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.

Implantable cardioverter-defibrillator aids in the prevention of cardiac arrest by delivering an electrical shock in the presence of life-threatening ventricular arrhythmias. Although implantable card...

Forgotten patients: ACO attribution omits those with low service use and the dying.

Alternative payment models, such as accountable care organizations, hold provider groups accountable for an assigned patient population, but little is known about unassigned patients. We compared clin...

Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.

The implantable cardioverter defibrillator provides effective treatment for the prevention of sudden cardiac arrest but significant risks associated with transvenous implantation persist. The subcutan...

Totally implantable active middle ear implant: Hearing and safety results in a large series.

To evaluate hearing performance and safety measures in a large group of totally implantable active middle ear implant (AMEI) wearers.

The Provider's Body in the Therapeutic Relationship: How Complementary and Alternative Medicine Providers Describe Their Work as Healers.

Although the body is central to health outcomes, the provider's body has been largely absent in the provider-patient relationship. Drawing upon semi-structured interviews with complementary and altern...

Clinical Trials [5030 Associated Clinical Trials listed on BioPortfolio]

Assessment of Appropriate Implantable Cardioverter Defibrillator (ICD) Implantation for Primary Prevention of Sudden Cardiac Death

Prophylactic implant of an ICD (implantable cardioverter defibrillator) for prevention of sudden cardiac death from a life-threatening heart rhythm abnormality is a standard recommendatio...

Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored

Multicentric, observational, retrospective registry including patients underwent implantable device implantation (pacemaker or ICD) for any indication in the period from 2009 to 2016, foll...

Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagement on Outcomes in the Merlin.Net™

Remote monitoring of implantable cardioverter-defibrillators (ICDs) for patients has led to efficient, safe, and satisfying analysis of their device and cardiac status; resulting in an ove...

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination amo...

Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System

The purpose is to further evaluate the operation, safety, and feasibility of a subcutaneous implantable defibrillator (S-ICD) system in patients who require an implantable cardioverter def...

Companies [2303 Associated Companies listed on BioPortfolio]

Implantable Provider Group

Implantable Provider Group streamlines the management and delivery of implantable medical devices by working directly with commercial insurance payors, clinical providers and faci...

Implantable Provider Group (IPG)

Access MediQuip, LLC

Access MediQuip was founded in 1997 and is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufactur...

TYRX®, Inc.

TYRX, Inc. commercializes innovative, implantable combination drug+device products focused on infection control, including the AIGISRx® Antibacterial Envelope, designed to redu...

Secant Group

Secant Group engineers medical textiles and biomedical structures that enable repair, recovery, and regeneration of the human body. Using advanced polymers, metals and composites,...

More Information about "Implantable Provider Group (IPG)" on BioPortfolio

We have published hundreds of Implantable Provider Group (IPG) news stories on BioPortfolio along with dozens of Implantable Provider Group (IPG) Clinical Trials and PubMed Articles about Implantable Provider Group (IPG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Implantable Provider Group (IPG) Companies in our database. You can also find out about relevant Implantable Provider Group (IPG) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record